Serum adipokines and low density lipoprotein subfraction profile in hypopituitary patients with growth hormone deficiency

Salman S., Uzum A. K. , Telci A. G. S. , Alagol F., Ozbey N. C.

PITUITARY, cilt.15, ss.386-392, 2012 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 15 Konu: 3
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1007/s11102-011-0332-1
  • Dergi Adı: PITUITARY
  • Sayfa Sayıları: ss.386-392


The aim was to evaluate the concentrations of lipid subfractions in relation to adipokines and metabolic parameters in adult growth hormone (GH)-deficient hypopituitary patients on conventional replacement therapy. The study included 21 GH deficient-hypopituitary patients (age: 36.0 +/- A 15.1 years, male/female: 7/14) on conventional replacement therapy other than GH and 20 comparable controls (age: 37.3 +/- A 14.0 years, male/female: 6/14). Lipid subfractions (Lipoprint system), serum adipokine (leptin, adiponectin, resistin) concentrations, body composition, a surrogate marker for insulin resistance (HOMA) and conventional lipid profile were evaluated. No statistically significant difference was found with respect to HOMA, adipokine concentrations and anthropometric parameters between patients and controls except for significantly increased waist-to-hip ratio in hypopituitary group. Total and LDL cholesterol concentrations were significantly higher in the patients. LDL particle size (268.88 +/- A 3.16 vs. 271.31 +/- A 3.11 a"<<, P = 0.151) and small-dense LDL subfraction did not differ significantly. According to logistic regression analysis, triglyceride concentrations a parts per thousand yen1.69 mmol/L was the sole parameter significantly and independently predicted small (< 268 a"<<) LDL particle size (P = 0.019) in the whole group. Increased triglyceride concentrations affect LDL particle size in GH-deficient hypopituitary patients. Small dense LDL seems not directly contribute to atherogenic potential in hypopituitarism.